Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
BASEL (Reuters) - Roche aims to have an immunotherapy cancer drug in 11 late-stage trials by the end of the year, the Swiss drugmaker's head of ...
Roche on track for 11 cancer immunotherapy candidates in late-stage trials by year-end (RHHBY) - Seeking Alpha
Dr. McCarthy will provide an overview of CytomX's Probody™ pipeline, including the company's precision cancer immunotherapy programs.
In an April 13 joint special issue on cancer, immunity, and immunotherapy, Cancer Cell and Trends in Immunology explore the history of this work and ...
The current Phase 3 trial forms the basis for the Gradalis personalized immunotherapy program. The ovarian cancer program is the first of several ...
A drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of Southampton. It has shown ...
Identification of immunotherapy biomarkers may prove 'very difficult' ... of internal medicine at Yale University and the Yale Comprehensive Cancer Center, ... There are a number of immunotherapies in melanoma — such interleukin ...
Immunotherapies which activate the immune system to attack cancer cells are already being performed domestically, but patients in advanced stages ...
Your immune system is educated from birth to recognize the difference ... virus-infected cancer cells know how to shut down the immune system and ...
... for Cancer Research (AACR) Annual Meeting in Philadelphia on April 22. ... that harness the body's own immune system in the fight against cancer.
Cancer patients are more likely to get infections. ... pneumonia cases in cancer patients were due to the immune system debility caused by the disease ...
“Dr. Shaw is a Key Opinion Leader in head and neck cancer who has ... way to activate the immune system to fight cancer and infectious diseases.
All exercise makes your immune system a better cancer fighter. We believe every one of you has an inner Amazonian who will fight for better health.
Drug delivery can be measured with fluorescence imaging, which is not a conventional tool in managing pancreatic cancer because it requires special ...
Dallas, Texas - A genetic analysis led by UT Southwestern Medical Center researchers suggests that most pancreatic cancers harbor genetic ...
Trials so far have shown the treatment is safe and tolerable for patients with pancreatic cancer. Researchers also are testing its safety in patients with ...
Blocking ADAM8 in mice with pancreatic cancer prevented the spread of the disease, shrunk tumours and significantly extended lifespan. This is ...
Motley Fool
In other words, there is no "average" cancer case that physicians will take on, ... including prostate, breast, colon, lung, brain, and pancreatic cancer.
Patients with blood in their urine shouldn't delay seeing their doctors, who should promptly refer them for tests to rule out bladder cancer, urologists ...
Science Daily Cancer News
Researchers have identified the precise temperature that results in a distinct body-wide antitumor immune response that resists metastatic disease.
Cell division research expected to lead to containment of cancer cells and regenerative medical treatments
All organisms grow and develop through the regenerative ability of cell division. An indispensable ability for all living beings, it can be said that life is defined by this process. Now, for the first time in the world, researchers have replicated the contractile ring’s structure by isolating a refined protein and placing it within a cell-imitation capsule.
To treat inoperable tumors, anti-cancer medicine is commonly used. However, efficient drug delivery to tumor cells is often difficult, treating an entire tumor with drugs even more so. A new highly efficacious anti-cancer nanotechnology has been developed by researchers that delivers anti-cancer drugs uniformly to an entire tumor.
A drug with the potential to reverse resistance to immunotherapy has been developed by scientists, showing great promise in pre-clinical models. Researchers say that it will be available to patients with certain leukemias and non-Hodgkin lymphomas in clinical trials later this year. Targeted drugs made from engineered immune proteins -- called monoclonal antibodies -- have revolutionized treatment for several types of cancer in recent years.
In response to nutrient excess, the MCRS1 protein acts as a 'switch' for mTOR, a protein that is altered in cancer, diabetes and disorders associated with aging. These results correlate with increased MCRS1 protein levels in samples taken from patients with colorectal cancer. Blocking this protein may prove to be an effective treatment for cancer or other diseases associated with mTOR alterations, researchers say.
Melanoma cells become drug resistant by using surrounding healthy cells to provide a ‘safe haven’ from treatment, according to new research. So even if some cancer cells are destroyed, the protected cancer cells may survive -- and the disease can recur in a form that is untreatable. Now scientists are focusing on these 'safe havens' for future melanoma treatment.
Cancerous tumors have the ability to evade targeted therapies by activating alternative pathways. Tumors also contain cancer stem cells, believed responsible for metastasis and drug resistance. Now scientists have identified a drug target that addresses both of these challenges.
When people learn they have a lesion in their pancreas that could become pancreatic cancer, they often request frequent CT scans and biopsies, or surgery. Often the lesion is nothing to worry about. A team of international physicians has developed a profile of the patient most at risk of developing lesions that are most likely to develop into cancer.
A new study associates taking muscle-building supplements with an increased risk of testicular cancer. Men who used such pills and powders were more likely to have developed testicular cancer than those who did not, especially if they started before age 25, took more than one supplement, or used the supplements for three or more years.
A new collaborative study describes a way that lung tissue can regenerate after injury. The team found that lung tissue has more dexterity in repairing tissue than once thought.
A new study that adds more to the growing body of evidence that certain compounds found naturally in foods have specific effects that help prevent chronic diseases. Researchers have uncovered a mechanism by which polyphenols in green tea and apples affect a key signalling molecule, which could explain other studies that have shown how polyphenol-rich foods reduce risks of chronic diseases.
Pneumonia is the most frequent type of infection in cancer patients and it is associated with high mortality rates. Researchers have analyzed the factors associated with severe pneumonia in hospitalized cancer patients and suggest that personalized treatment protocols can reduce mortality in this population. Their work indicates that the standard broad-spectrum antibiotic treatment used by physicians worldwide may not be the better choice for this group.
A new study indicates that vaccinating 12-year-old boys against the human papilloma virus may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts at the back of the throat and mouth, and involves the tonsils and base of the tongue.
PCBs still found in fat-rich fish near Spain; Consumption linked to increased risk of cancer in males
Scientists have demonstrated that the exposure to a chemical pollutant called PCB-153 is positively associated to the risk of suffering from cancer in males. This agent, which has been banned in Spain since the 1980s, can still be found in some fat-rich food, such as large fat-rich fish (tuna, salmon, swordfish, among others), since it is highly resistant to degradation.
Stories involving cancer and its devastating consequences are a frequent occurrence in the news. We are constantly being told which foods may cause cancer, and which may prevent it, but how much is fact, and how much is fiction is often in dispute. The same is true for cancer survivors trying to find reliable nutritional information which will help them to improve their quality of life and prevent future relapses.
A biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer has been discovered by researchers. Worldwide, prostate cancer is the second-most common cancer in men. In the U.S., about 221,000 new cases of prostate cancer will be diagnosed in 2015, resulting in roughly 27,500 deaths.
Tambahkan Komentar